I nfective endocarditis (IE) remains a major clinical problem, with mortality rates of 20% to 40%. [1] [2] [3] During the active course of IE, neurological complications occur in 20% to 40% of patients 1, 4, 5 and have been linked to a poorer outcome. 1, 2, 5, 6 In several of the related reports, however, neurological complication is a generic term referring to a broad spectrum of complications ranging from nonspecific manifestations, such as nonfocal encephalopathy, seizures, or headache, to stroke or severe cerebral hemorrhage. 4,7 This all-inclusive approach can lead to confusion when investigating the true effect of brain involvement on the outcome of IE or the relationships between brain injury and certain characteristics Background-The purpose of this study was to assess the incidence of neurological complications in patients with infective endocarditis, the risk factors for their development, their influence on the clinical outcome, and the impact of cardiac surgery. Methods and Results-This was a retrospective analysis of prospectively collected data on a multicenter cohort of 1345 consecutive episodes of left-sided infective endocarditis from 8 centers in Spain. Cox regression models were developed to analyze variables predictive of neurological complications and associated mortality. Three hundred forty patients (25%) experienced such complications: 192 patients (14%) had ischemic events, 86 (6%) had encephalopathy/meningitis, 60 (4%) had hemorrhages, and 2 (1%) had brain abscesses. Independent risk factors associated with all neurological complications were vegetation size ≥3 cm (hazard ratio [HR] 1.91), Staphylococcus aureus as a cause (HR 2.47), mitral valve involvement (HR 1.29), and anticoagulant therapy (HR 1.31). This last variable was particularly related to a greater incidence of hemorrhagic events (HR 2.71). Overall mortality was 30%, and neurological complications had a negative impact on outcome (45% of deaths versus 24% in patients without these complications; P<0.01), although only moderate to severe ischemic stroke (HR 1.63) and brain hemorrhage (HR 1.73) were significantly associated with a poorer prognosis. Antimicrobial treatment reduced (by 33% to 75%) the risk of neurological complications. In patients with hemorrhage, mortality was higher when surgery was performed within 4 weeks of the hemorrhagic event (75% versus 40% in later surgery). Conclusions-Moderate to severe ischemic stroke and brain hemorrhage were found to have a significant negative impact on the outcome of infective endocarditis. Early appropriate antimicrobial treatment is critical, and transitory discontinuation of anticoagulant therapy should be considered. The online-only Data Supplement is available with this article at http://circ.ahajournals.org/lookup/suppl/
Echocardiography
Transthoracic echocardiography was performed in all patients. Vegetations were measured in 2 orthogonal dimensions at the point in the cardiac cycle when the oscillating mass appeared the largest, with the greatest diameter obtained recorded. Transesophageal echocardiography has been available in our centers since 1995 and was performed in the following situations: (1) When strong clinical suspicion remained after a nondiagnostic transthoracic echocardiography and (2) to better evaluate the valve complications.
Microbiology
Microbiological information was obtained from culture of blood and intraoperative heart tissue specimens, as well as from serological studies. Blood cultures were always performed serially (minimum of 2 separate samples) and processed by the automated methods used at each center.
Definitions
Neurological complications were classified into the following categories: Meningitis-encephalopathy, ischemic complications, cerebral hemorrhage, and brain abscess. Encephalitis was defined as mental changes or stupor, with no focal neurological signs and no abnormal computed tomography (CT) findings. The diagnosis of meningitis required cerebrospinal fluid pleocytosis, with or without isolation of the causal microorganism on culture. The diagnosis of ischemic and hemorrhagic complications was based on clinical and radiological data. Ischemic complications were divided into 2 groups according to CT imaging and clinical findings: small ischemic complication, which included transient ischemic attack or minor infarction (embolism affecting <30% of 1 brain lobe), and moderate-severe ischemic complication, which was defined as multiple cerebral embolisms or a single embolism affecting ≥30% of a brain lobe. Hemorrhagic complication included primary intracerebral hemorrhage, hemorrhagic infarction, and subarachnoid hemorrhage. CT scanning of the brain was performed based on clinical suspicion. The diagnosis of mycotic aneurysm was always supported by cerebral arteriography. Patients with brain abscesses, diagnosed by CT, were included in the overall group of neurological complications for the analyses.
Comorbidity and Other Complications
The Charlson Index score 12 was determined at hospital admission to evaluate the type and severity of the patient's underlying comorbidity. The additive EuroSCORE (European System for Cardiac Operative Risk Evaluation) index 13 was calculated in each case to determine the cardiac operative risk. Heart failure was defined according to the Framingham criteria 14 and was evaluated at admission and over the patient's clinical course. Septic shock was defined by standard criteria. 15 Acute renal failure was established on the basis of a creatinine concentration >1.5 mg/dL in patients with normal renal function previously or a decrease of >25% of the previous creatinine clearance in patients with chronic renal insufficiency.
Mortality and Follow-Up
Early mortality was defined as a death that occurred during hospitalization regardless of cause or within 1 month of discharge if it was related to the IE episode. If the cause of death during this period was unknown (eg, sudden death after discharge with no autopsy or insufficient information on cause), it was also considered IE-related. Deferred mortality was defined as death that occurred during the follow-up period after the first month and that resulted from the consequences of endocarditis, such as late ventricular failure or neurological injury.
Clinical follow-up continued for 1 year, with scheduled visits at 1, 3, 6, and 12 months. At least 1 echocardiographic examination was performed during this period to evaluate the need for deferred surgery. Follow-up blood cultures were performed 2 months after completion of antimicrobial treatment to ensure definite microbiological cure. Cases with insufficient follow-up (<1 month after discharge) were excluded.
Because of recent advances in the diagnosis (microbiological procedures, magnetic resonance imaging, and transesophageal echocardiography), medical treatment, and cardiac surgery, the data were divided into 2 time periods and analyzed separately: 1984 to 1995 and 1996 to 2009.
Statistical Analysis
Continuous variables were not adjusted on normal distribution and were compared with the Mann-Whitney U test. Results are expressed as the median and interquartile range. Univariate associations for proportions were performed with a 2-sided Pearson correlation coefficient. The χ 2 test or Fisher exact test were used for statistical inference, and the Bonferroni correction was applied for multiple comparisons.
To evaluate the effect of antimicrobial treatment in reducing neurological complications, the standardized risk difference was calculated: The residual risk that remained after 1 week of appropriate antimicrobial treatment was subtracted from the risk obtained during the first week of treatment, and the result was divided by the risk during the first week.
To determine the independent effect of the variables on early mortality and the association of risk factors with the various neurological complications, multivariable Cox regression models were performed.
Variables showing a significance of <0.05 in the univariate analysis were included, and forward stepwise Cox regression was performed, adjusted by the Wald statistic. We used the default level of significance of 0.05 for entry and 0.10 for removal of variables from the analysis. Adjusted hazard ratios (HRs) and their 95% confidence intervals (CIs) were calculated for each variable. Model goodness of fit was assessed by the Atkinson R 2 coefficient. 18 The risk factor analysis was performed only for early mortality. Deferred mortality is presented as descriptive data. Statistical significance was set at P<0.05. Data were analyzed with SPSS version 18.0 (Chicago, IL) software. All reported probability values were based on 2-tailed tests.
Results

Demographic Features
Seventy-three cases were excluded because of missing data (n=46) or insufficient follow-up (n=27). A total of 1345 episodes of left-sided IE were ultimately included: 1247 (93%) definite IE and 98 (7%) possible IE. Among the 1018 patients from Andalusia, 833 (82%) were first attended in the referral hospitals, whereas 185 (18%) were transferred from hospitals without cardiac surgery departments (76 from the 2 participating community hospitals and 109 from other centers). Vall d'Hebron Hospital in Barcelona recorded 327 cases, and 34% of them were transferred patients. There were no significant differences between the patients registered in the 2 databases (online-only Data Supplement), and the percentage of neurological complications occurring in transferred patients was not significantly different from that of patients initially seen in the referral hospitals (23% versus 27%; P=0.1).
The epidemiological and microbiological characteristics of the patients studied, divided into 2 time periods, are summarized in Table 1 . On comparison of patients in the 2 periods analyzed, the median age, comorbidities, healthcare origin, and cases caused by S aureus, enterococci, and Streptococcus bovis were higher in the second period. The cardiac surgery and mortality rates were also higher in the second period. 
Neurological Complications
Predictors of Neurological Complications
The risk factors associated with the development of all neurological complications were vegetation size ≥3 cm (HR, 1.91; 95% CI, 1.07-3.43; P=0.029), S aureus as the cause of IE (HR, 2.47; 95% CI, 1.94-3.15; P<0.001), anticoagulant therapy at IE diagnosis (HR, 1.31; 95% CI, 1.00-1.72; P=0.048), and mitral valve involvement (HR, 1.29; 95% CI, 1.02-1.61; P=0.03). Further analysis showed that elderly patients (≥70 years) had lower complication rates than younger ones, and only hemorrhagic events showed statistical significance (HR, 0.36; 95% CI, 0.16-0.83; P=0.014). Anticoagulant treatment was particularly associated with cerebral hemorrhage (HR, 2.71; 95% CI, 1.54-4.76; P=0.001; Tables 2 and 3 ).
The distribution of each neurological complication relative to the time point antibiotics were started is illustrated in Figure 1 . The neurological event was the first sign of IE in 100 patients (7% of the total IE cohort), occurring before the start of antimicrobial treatment, and in 192 patients (14%) the complication occurred during the first week of treatment. Thus, in 292 of the 340 affected patients (86%), the neurological complication was observed before or during the first week of treatment, with a subsequent gradual decrease during the following weeks: 32 episodes in the second week, 9 in the third, and only 5 episodes after 4 weeks of treatment. After 1 week of appropriate antimicrobial treatment, the incidence of neurological complications showed a marked decrease (4% of the total cohort), although this reduction was lower for hemorrhagic events ( Figure 1A) . The decrease was similar in IE caused by streptococci and staphylococci, but was less evident in cases caused by enterococci or unknown causes (Table 4 ). Vegetations >1 cm were also associated with a less 
Valve
Native valve 1020 (76) 261 (26) 71 (7) 145 (14) 102 (10) 43 (4) 43 (4) Prosthetic valve 325 (24) 79 (24) 15 (5) 47 (14) 36 (11) 11 (3) 17 (5) Mechanical 230 (17) 63 (27) pronounced risk decrease after treatment, and in those with diameters ≥3 cm, the incidence of embolic events after the first week of treatment remained very high (20%). In patients whose anticoagulant therapy was maintained, the risk reduction was also less marked because of the greater number of hemorrhagic events (10/19 versus 9/31; P=0.06), with no reduction in the rate of ischemic events.
Risk Factors for Mortality
Early mortality in the cohort was 30% (n=401); no differences were observed between patients who underwent surgery (31%) and those receiving medical treatment (29%) alone. The causes of death were ventricular failure (n=179; 45%), sepsis (n=93; 23%), vascular neurological event (n=40; 10%), and others (n=89; 22%), mostly related to complications in the postoperative period (n=42; 47%).
Neurological complications had a negative impact on the outcome. In patients who experienced a neurological event, early mortality was 45% compared with 24% in patients who did not have this complication (HR, 1.58; 95% CI, 1.23-2.02; P<0.001). Nonetheless, only cerebral hemorrhage and moderate-severe ischemic events were independently associated with mortality in the adjusted multivariable analysis ( Table 5 ).
The other independent risk factors associated with early mortality were septic shock (HR, 2.24; 95% CI, 
Surgery and Neurological Complications
Surgery was indicated in 710 patients (53%) but was performed in only 523 patients (39%). A smaller percentage of patients with neurological complications underwent surgery (109/340, 32%) than patients without these complications (414/1005, 41%; P<0.01). Sixty-two patients with neurological complications (18%) had an indication for surgery but were not operated on because of deteriorated neurological status or unacceptable operative risk versus 114 patients without these complications (11%; P<0.01).
Only 12 (20%) of 60 patients with cerebral hemorrhage underwent surgery, and mortality was high when the procedure was performed within the first 2 weeks (3 of 4 cases), in the third week (2 of 3 cases), and 21 days after the neurological event (2 of 5 cases). Of note, 4 of these 7 deaths were related to new severe bleeding after cardiac surgery. The percentage of new bleeds postoperatively was 50% (2 of 4 cases) in surgery performed in the first 2 weeks, 33% (1 of 3 cases) in surgery in the third week, and 20% (1 of 5 cases) in surgery performed 21 after days of the neurological event ( Figure 2 ; Table 6 ).
Fifteen (28%) of 54 patients with moderate-severe ischemic lesions also underwent surgery, 5 of them within 2 weeks of the neurological event (2 deaths) and 10 after 2 weeks (2 deaths). Two of these 4 deaths were related to new cerebral bleeding. Thirty-eight patients (70%) who had small ischemic complications and underwent surgery in the first 2 weeks showed higher mortality than those with no neurological events (18/38 [47%] versus 77/257 [30%]; P=0.032), but higher mortality was also observed when surgery was performed after 2 weeks (8/16 [50% mortality]; Figure 2B ). The percentage of bleeding events and exacerbation of neurological symptoms in this group was 11% in the first week, 10% in the second, and 27% in the third week; there were no cases after 21 days (Table 6 ). Of note, 8 (2%) of 393 patients who underwent surgery with no apparent neurological complications experienced a cranial hemorrhage in the postoperative period; 6 of them had been operated on within 14 days after the diagnosis.
Discussion
This observational study describes the incidence of neurological complications in a large, well-defined multicenter cohort of left-sided IE patients, analyzes the risk factors for developing these complications, and describes the effect on them of antimicrobial treatment and anticoagulant therapy. In addition, the outcome of early surgery in these patients was investigated to assess the risk of new time-dependent neurological damage. The traditional therapy for IE concentrates on bacteriological cure of the infected heart valve and surgical correction of hemodynamic decompensation. Neurological complications are a common and often salient feature of IE, 1-5 and the advent of CT and magnetic resonance imaging enables a more reliable clinical assessment of stroke syndromes. However, there are few available data about the risk of recurrent stroke, the best approach with regard to anticoagulant therapy, or the consequences of early surgery.
The overall frequency of neurological complications in the present study cohort was 25%, and 19% were vascular events, in keeping with the results from other large cohorts. 8, 19 In the present series, the majority of cases were first attended in referral centers, but patients transferred from other institutions were also included. The percentage of complicated cases may have been somewhat overrepresented, with patients from community hospitals accounting for 23% of the total. Nonetheless, other multicenter studies only include cases from referral centers; hence, it is likely that the present series better reflects the overall clinical reality of this patient population.
We found that the percentage of neurological complications did not change substantially between the 2 periods studied except for hemorrhagic complications, which showed a decrease in more recent years, which contrasted with the increase in patient age. Older patients in the present study had lower rates of these events, as has been reported previously, 8, 20 but the cause of this reduction is not fully understood. Use of antiplatelet therapy 21, 22 (often prescribed in elderly patients), a hypothetical decline in hemostatic function, and smaller size of vegetations in this population are some of the proposed reasons, 3 but it is also possible that these events are simply Mitral valve involvement and vegetation size have been considered important predictors of stroke in several studies, 3,8,10,23-26 whereas others have not confirmed this observation. [27] [28] [29] [30] Some authors have emphasized the importance of vegetations only when other factors are present, such as large size, mitral valve location, and S aureus as the cause of IE. 27, 30 In the present cohort, mitral endocarditis was a mild risk factor for a greater rate of ischemic complications, and vegetation size showed a significant association, but only in relation to larger diameters. Therefore, we believe that the real prognostic influence of vegetation size and location on the development of embolic events may be outweighed by other factors that appear to be more important, such as the causal microorganism. Staphylococcus aureus as the causal microorganism was the most important risk factor for all neurological complications in the present study, and its impact was 2 to 3 times higher than that of other causative agents.
Appropriate antimicrobial treatment considerably decreased the embolism rate after 1 week, and this effect was observed with all the microorganisms implicated, as has been reported previously. 10, 31 The comparatively smaller reduction seen in the present study in relation to enterococci or unknown causes likely reflects the difficulty to obtain a bactericidal activity with the antimicrobial treatment used in these 2 scenarios. Nonetheless, even in the best microbiological context, in patients with very large vegetations (≥3 cm diameter), the risk of developing a neurological complication after 1 week of medical therapy remained very high. This fact should be borne in mind when making important clinical decisions, such as the need for an early surgical intervention. Prompt surgery to prevent embolic events based on a vegetation size >1 cm was proposed in early echocardiographic studies, 32 but greater percentages of relapse and prosthesis dehiscence after surgery when antimicrobial treatment has not been completed remain a concern. In this regard, 2 recent studies have demonstrated that early surgery effectively decreases systemic embolism without increasing the IE relapse rate or prosthetic valverelated problems compared with conventional treatment. 33, 34 Not all neurological complications had a negative impact on the outcome, and this could explain in part the contradictory results of several studies in which the various types of complications were not differentiated. 4, 8 Furthermore, standardized severity grading (clinical or radiological) of cerebrovascular complications is provided in very few reports. 19 In the present study, only moderate-severe ischemic events, particularly cerebral hemorrhages, were significantly associated with a poorer outcome, as has been pointed by others. 35 Hemorrhagic complications were clearly related to S aureus and anticoagulant therapy, which was mainly used in patients with mechanical valves. Furthermore, patients in whom anticoagulant therapy was maintained experienced a larger number of hemorrhagic events, even after 1 week of antimicrobial therapy. On the basis of these results, we agree with the recommendations of Tornos et al, 36 who advise temporary discontinuation of anticoagulant therapy in cases of S aureus IE until the septic phase of the disease is overcome and the risk of embolization has decreased with antimicrobial therapy. Future studies are needed to further clarify this important point.
In the present study, cardiac surgery was strongly conditioned by the development of neurological complications, with a considerably lower number of interventions when they were present, even in patients with a clear indication for valve repair. The impact of valve surgery on the outcome in IE patients with cerebrovascular complications is a subject of debate, and there is a great deal of concern about the risk of postoperative neurological impairment when surgery is performed early after an ischemic or hemorrhagic episode. The literature contains contradictory results in this line: Some authors have found the risk of exacerbation to be low when surgery was performed within 72 hours, 37 whereas others have reported that the risk is highest in early surgery and gradually decreases as the delay between the neurological event and the operation increases. 9 Because of the lack of controlled studies, recommendations are based on the results of published reports, and the generally accepted advice is to delay surgery for ≥2 weeks in the case of severe ischemic strokes and 4 weeks for hemorrhagic events. 38 The results of the present study are in line with these recommendations, although the risk of postoperative complications was low after a small ischemic event, and therefore, minor events should not be an impediment to surgical valve repair when it is necessary.
The present study has several limitations. First, brain CT scans were not routinely performed in all patients, and the true incidence of ischemic complications is likely underestimated in the present cohort. Studies using magnetic resonance imaging [39] [40] [41] have shown that acute brain embolizations are significantly more prevalent than has been reported previously in studies based on clinical findings and CT scanning (30% of undetected events). With this taken into account, it is possible that some less symptomatic elderly patients in the present study were wrongly classified as having no neurological complications and that several patients with negative CT scans and symptoms labeled as encephalitis may have had multiple small embolisms that would have been detected with other imaging techniques. However, other reports 19, 42 have shown that small ischemic complications have no effect on the final outcome of IE (in accordance with the present findings), and therefore, the essential conclusions would not be changed. Second, because of the lengthy recruitment of this cohort (>20 years), transesophageal echocardiography was only available in the second study period, and therefore, echocardiographic reading was not centralized or blinded to clinical status. Hence, evaluation of the echocardiographic data (vegetation size) may be biased. It would not be inconceivable for an echocardiographer with knowledge of the patient's clinical course (eg, a neurological event), to unconsciously exercise bias when interpreting the severity of the echocardiographic features. Furthermore, many echocardiographic studies were performed after neurological complications had developed, and it is likely that vegetation size was larger before the embolism; however, this further supports the fact that large vegetations are a particularly important risk factor for these events. Third, this was an observational study, and some results, such as the effect of cardiac surgery on neurological complications, should be interpreted with caution. The multicenter character of the cohort implies that there may have been somewhat different approaches between the hospitals regarding aspects such as surgical treatment or the timing of surgery after the event.
Nonetheless, there were no significant differences in the operation rates or mortality between the participating hospitals with cardiac surgery departments (data not shown), and the increase in operations in the second period likely reflects the current trend toward more proactive and earlier surgery in IE. 43, 44 
Conclusions
The results of the present study may help to identify IE patients who are at an increased risk of neurological complications. The outcome in this population appears to depend on the type of event, with moderate-severe ischemic strokes and brain hemorrhage being associated with a significant excess in mortality. It is advisable to revise anticoagulant therapy in episodes associated with a high risk of neurological events, such as cases caused by S aureus, mitral valve involvement, and large vegetations. Despite appropriate antimicrobial treatment, which clearly reduces the rate of events after 1
week, large vegetation size should lead to consideration of an early surgical intervention. Even though valve repair may exacerbate cerebral damage after cerebrovascular events, the risk of postoperative bleeding appears to be low in cases with small ischemic strokes when surgery is performed immediately and in moderate-severe episodes when the intervention takes place after 2 weeks. In patients with cerebral hemorrhage, it may be advisable to postpone valve replacement for ≥4 weeks. 
CLINICAL PERSPECTIvE
This observational study describes the incidence of neurological complications in a large, well-defined multicenter cohort of left-sided infective endocarditis. The risk factors for developing these events were analyzed carefully, and the influence of antimicrobial treatment and anticoagulant therapy in this scenario was considered. In addition, the results of early surgical intervention in this context were evaluated to assess the risk of new neurological damage that was time dependent. In the present study, vegetation size ≥3 cm, Staphylococcus aureus as the causative microorganism, and involvement of the mitral valve were risk factors related to the development of neurological complications; conversely, antimicrobial treatment reduced their incidence. Moderate to severe ischemic strokes and brain hemorrhages were associated with a significantly worse prognosis, and maintenance of anticoagulant therapy was associated with a higher incidence of hemorrhagic events. Finally, a higher mortality was observed when valvular surgery was performed within 4 weeks of a brain hemorrhage. The conclusion is that early and appropriate antimicrobial treatment is critical to avoid neurological complications in infective endocarditis and that a temporary withdrawal of anticoagulant therapy should be considered. Valvular surgery should be deferred when hemorrhage is present. 
Anticoagulant therapy
Patients receiving anticoagulation were classified into 4 groups 1. Patients in whom anticoagulant therapy with dicoumarin was continued after the IE diagnosis and during the entire episode if no neurological event occurred, or until the neurological event presented. These patients were considered as "receiving anticoagulant therapy".
2. Patients in whom dicoumarin was switched to heparin after the IE diagnosis, following the same scheme as above. These patients were also considered as "receiving anticoagulant therapy"
3. Patients in whom any form of anticoagulation was temporarily discontinued (one to two weeks) after the IE diagnosis and with a clinically suspected vascular neurologic event. This therapy was re-started if there were no neurological events after initiation of antimicrobial therapy. These patients were classified as "no anticoagulant therapy" and the effect of dicoumarin was reversed in the preceding 24 hours with vitamin K administration.
4.
Patients in whom anticoagulants were discontinued at the time of the IE diagnosis, and with high clinical suspicion of a neurological event. The suspected event was then confirmed or ruled out based on the patients' clinical course and/or CT findings. This group was excluded from the analysis.
The following flow chart shows the final distribution of patients and the outcome according to the therapeutic decision:
Second box down on the right, after 14.8% : Anticoagulant therapy use after IE diagnosis was unknown The only significant difference is that physicians tended to temporary discontinue anticoagulation in elderly patients.
The following two tables depict the risk of vascular neurologic events (ischemic or hemorrhagic) according to whether patients were receiving anticoagulation or not. Data from the total cohort are shown in Table 5 and data only from patients with prosthetic valve IE are presented in Table 6 . 
